GPCR signaling is inherently multidimensional, and single-endpoint assays may overlook critical pharmacological responses. Discover how combining HTRF™ cAMP, IP-One and GTP/Gi assays provides a comprehensive characterization of receptor activity across Gαs, Gαq and Gαi pathways.
Key takeaways:
For research use only. Not for use in diagnostic procedures.
Multidimensional screening platform of GPCR-targeting compounds with HTRF assays